Tailoring peritoneal dialysis fluid for optimal acid-base targets

Contributions to Nephrology

Volumn 163, Issue , 2009, Pages 67-73

  Feriani, Mariano ^a  

^a Dell'Angelo Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BUFFER; DIALYSIS FLUID;

ACID BASE BALANCE; ACIDOSIS; ARTICLE; CHRONIC KIDNEY FAILURE; HUMAN; METHODOLOGY; PATHOPHYSIOLOGY; PERITONEAL DIALYSIS; PH; PHYSIOLOGY; STANDARD;

ACID-BASE EQUILIBRIUM; ACIDOSIS; BUFFERS; DIALYSIS SOLUTIONS; HUMANS; HYDROGEN-ION CONCENTRATION; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS;

EID: 67651210856     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000223782     Document Type: Article

References (32)

1. Feriani M: Adequacy of acid base correction in Continuous Ambulatory Peritoneal Dialysis. Perit Dial Int 1984;14(suppl 3):S133-S138.
2. Uribarri J, Buquing J, Oh MS: Acid-base balance in peritoneal dialysis patients. Kidney Int 1995;47:269-273.
3. Bichara M, Mercier O, Borensztein P, Paillard M: Acute metabolic acidosis enhances circulating parathyroid hormone, which contributes to renal response against acidosis in the rat. J Clin Invest 1990;86:430-443.
4. Lefebvre A, de Verneoul MC, Gueris J, Goldfarb B, Graulet AM, Morieux C: Optimal correction of acidosis changes progression of dialysis osteodystrophy. Kidney Int 1989;36:1112-1118.
5. Graham KA, Hoenich NA, Tarbit M, Ward MK, Goodship THJ: Correction of acidosis in hemodialysis patients increases the sensitivity of the parathyroid glands to calcium. J Am Soc Nephrol 1997;8:127-631.
6. Hutchison AJ, Freemont AJ, Boulton HF, Gokal R: Low calcium dialysis fluid and oral calcium carbonate in CAPD: a method of controlling hyperphosphatemia whilst minimizing aluminum exposure and hypercalcaemia. Nephrol Dial Transplant 1992;7:1219-1225.
7. May RC, Kelly RA, Mitch WE: Mechanisms for defects in muscle protein metabolism in rats with chronic uremia: the influence of metabolic acidosis. J Clin Invest 1987;79:1099-1103.
8. May RC, Kelly RA, Mitch WE: Metabolic acidosis stimulates protein degradation in rat muscle by a glucocorticoid-dependent mechanism. J Clin Invest 1986;77:614-621.
9. Hara Y, May RC, Kelly RA, Mitch WE: Acidosis, not azotemia, stimulates branched-chain amino acid catabolism in uremic rats. Kidney Int 1987;32:808-814.
10. Mitch WE, Clark AS: Specifi city of the effect of leucine and its metabolites on protein degradation in skeletal muscle. Biochem J 1984;222:579-586.
11. Papadoyannakis NJ, Stefanides CJ, Mc Geown M: The effect of the correction of metabolic acidosis on nitrogen and protein balance of patients with chronic renal failure. Am J Clin Nutr 1984;40:623-627.
12. Reaich D, Channon SM, Scrimgeour CM, Daley SE, Wilkinson R, Goodship THJ: Correction of acidosis in humans with chronic renal failure decreases protein degradation and amino acid oxidation. Am J Physiol 1993;265:E230-E235.
13. Jenkins D, Burton PR, Bennet SE, Baker F, Walls J: The metabolic consequences of the correction of acidosis in uraemia. Nephrol Dial Transpl 1989;4:92-95.
14. Williams B, Hattersley J, Layward E, Walls J: Metabolic acidosis and skeletal muscle adaptation to low protein diets in chronic uremia. Kidney Int 1991;40:779-786.
15. Bergström J, Alvestrand A, Furst P: Plasma and muscle free amino acids in maintenance hemodialysis patients without protein malnutrition. Kidney Int 1990;38:108-114.
16. Garibotto G, Russo R, Sofi a A, Sala MR Robaudo C, Moscatelli P, Deferrari G, Tizianello A: Skeletal muscle protein synthesis and degradation in patients with chronic renal failure. Kidney Int 1994;45:1432-1439.
17. Ballmer PE, Mc Nurlan MA, Hulter HN, Anderson SE, Gatlick PJ, Krapf R: Chronic metabolic acidosis decreases albumin synthesis and induces negative nitrogen balance in humans. J Clin Invest 1995;95:39-451994.
18. Graham KA, Reaich D, Channon SM, Downie S, Goodship THJ: Correction of acidosis in hemodialysis decreases whole-body protein degradation. J Am Soc Nephrol 1997;8:632-637.
19. Graham KA, Reaich D, Channon SM, Downie S, Gilmour E, Passlick-Deetjen J, Goodship THJ: Correction of acidosis in CAPD decreases whole-body protein degradation. Kidney Int 1996;49:1396-1400.
20. Gennari FJ: Acid-base homeostasis in end-stage renal disease. Semin Dialy 1996;9:404-411.
21. Gennari FJ: Acid-base balance in dialysis patients. Kidney Int 1985;28:678-688.
22. Gennari FJ: Normal acid base values; in Cohen JJ, Kassirer JP (eds): Acid Base. Boston, Little, Brown, 1982, pp 107-110.
23. Feriani M: Buffers: bicarbonate, lactate, pyruvate. Kidney Int 1996;50(suppl 56):S75-S80.
24. Nolph KD, Prowant B, Serkes KD, et al: Multicenter evaluation of a new peritoneal dialysis solution with a high lactate and low magnesium concentration. Perit Dial Bull 1983;3:63-65.
25. Stein A, Moorhouse J, Iles-Smith H, et al: Role of an improvement in acid-base status and nutrition in CAPD patients. Kidney Int 1997;52:1089-1095.
26. Feriani M, Passlick-Deetjen J, La Greca G: Factors affecting bicarbonate transfer with bicarbonate-containing CAPD solution. Perit Dial Int 1995;15:336-341.
27. Feriani M, Biasioli S, Borin D, et al: Bicarbonate buffer for CAPD solution. Trans Am Soc Artif Intern Organs 1985;31:668-672.
28. Traneus A, for the Bicarbonate/Lactate Study Group: A long-term study of a bicarbonate/lactate-based peritoneal dialysis solution: clinical benefits. Perit Dial Int 2000;20:516-523.
29. Feriani M, Kirchgessner J, La Greca G, Passlick-Deetjen J, Bicarbonate CAPD Cooperative Group: A randomized multicenter long-term clinical study comparing a bicarbonate buffered CAPD solution with the standard lactate buffered CAPD solution. Kidney Int 1998;54:1731-1735.
30. Otte K, Gonzalez MT, Bajo MA, et al: Clinical experience with a new bicarbonate (25 mmol/L)/ lactate (10 mmol/L) peritoneal dialysis solution. Perit Dial Int 2003;23:138-145.
31. Feriani M, Carobi C, La Greca G, Buoncristiani U, Passlick-Deetjen J: Clinical experiences with a bicarbonate buffered (39 mmol/l) peritoneal dialysis solution. Perit Dial Int 1997;17:17-21.
32. Feriani M, Passlick-Deetjen J, Jaeckle-Meyer I, La Greca G: Individualize bicarbonate concentration in the peritoneal dialysis fluid to optimize acid-base status in CAPD patients. Nephrol Dial Transplant 2004;19:195-202.